ARTICLE | Company News
Halozyme sales and marketing update
June 27, 2005 7:00 AM UTC
HTI launched Cumulase, an ex vivo formulation of recombinant human PH20 hyaluronidase, to treat oocytes to facilitate certain in vitro fertilization (IVF) procedures. ...